Efficacy and safety of canagliflozin alone or as add-on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52-week open-label study

por Inagaki, Nobuya, Kondo, Kazuoki, Yoshinari, Toru, Kuki, Hideki
Publicado 2015

Pharmacokinetic and Pharmacodynamic Profiles of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment

por Inagaki, Nobuya, Kondo, Kazuoki, Yoshinari, Toru, Ishii, Manabu, Sakai, Masaki, Kuki, Hideki, Furihata, Kenichi
Publicado 2014